| REMEDIAL II Trial of PLC's RenalGuard® Article Published in Circulation - PR Newswire (press release) |
|
|
PR Newswire (press release) The results from this trial showed that RenalGuard is superior to the current standard of care at preventing Contrast-Induced Nephropathy (CIN) and in-hospital dialysis in high-risk patients undergoing certain imaging procedures. |